145 related articles for article (PubMed ID: 27777084)
1. Crosstalk between the gut and the liver via susceptibility loci: Novel advances in inflammatory bowel disease and autoimmune liver disease.
Li X; Shen J; Ran Z
Clin Immunol; 2017 Feb; 175():115-123. PubMed ID: 27777084
[TBL] [Abstract][Full Text] [Related]
2. Gut-liver immunity.
Trivedi PJ; Adams DH
J Hepatol; 2016 May; 64(5):1187-1189. PubMed ID: 26686270
[TBL] [Abstract][Full Text] [Related]
3. The gut microbiota and inflammatory bowel disease.
Matsuoka K; Kanai T
Semin Immunopathol; 2015 Jan; 37(1):47-55. PubMed ID: 25420450
[TBL] [Abstract][Full Text] [Related]
4. Immunopathogenesis of inflammatory bowel diseases: functional role of T cells and T cell homing.
Zundler S; Neurath MF
Clin Exp Rheumatol; 2015; 33(4 Suppl 92):S19-28. PubMed ID: 26458165
[TBL] [Abstract][Full Text] [Related]
5. Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease.
Grant AJ; Lalor PF; Salmi M; Jalkanen S; Adams DH
Lancet; 2002 Jan; 359(9301):150-7. PubMed ID: 11809275
[TBL] [Abstract][Full Text] [Related]
6. Role of cell adhesion molecules in leukocyte recruitment in the liver and gut.
Ala A; Dhillon AP; Hodgson HJ
Int J Exp Pathol; 2003 Feb; 84(1):1-16. PubMed ID: 12694483
[TBL] [Abstract][Full Text] [Related]
7. Gut Homing Molecule Regulation of the Pathogenesis and Treatment of Inflammatory Bowel Diseases.
Evans-Marin HL; Cong Y
Inflamm Allergy Drug Targets; 2015; 14(1):4-12. PubMed ID: 26296210
[TBL] [Abstract][Full Text] [Related]
8. Joint involvement associated with inflammatory bowel disease.
De Vos M
Dig Dis; 2009; 27(4):511-5. PubMed ID: 19897967
[TBL] [Abstract][Full Text] [Related]
9. Neuro-glial crosstalk in inflammatory bowel disease.
Neunlist M; Van Landeghem L; Bourreille A; Savidge T
J Intern Med; 2008 Jun; 263(6):577-83. PubMed ID: 18479256
[TBL] [Abstract][Full Text] [Related]
10. Innate immunity in inflammatory bowel disease: state of the art.
Hisamatsu T; Ogata H; Hibi T
Curr Opin Gastroenterol; 2008 Jul; 24(4):448-54. PubMed ID: 18622158
[TBL] [Abstract][Full Text] [Related]
11. Comorbidity between depression and inflammatory bowel disease explained by immune-inflammatory, oxidative, and nitrosative stress; tryptophan catabolite; and gut-brain pathways.
Martin-Subero M; Anderson G; Kanchanatawan B; Berk M; Maes M
CNS Spectr; 2016 Apr; 21(2):184-98. PubMed ID: 26307347
[TBL] [Abstract][Full Text] [Related]
12. Immune deficiency vs. immune excess in inflammatory bowel diseases-STAT3 as a rheo-STAT of intestinal homeostasis.
Leppkes M; Neurath MF; Herrmann M; Becker C
J Leukoc Biol; 2016 Jan; 99(1):57-66. PubMed ID: 26232455
[TBL] [Abstract][Full Text] [Related]
13. MAdCAM-1 expressed in chronic inflammatory liver disease supports mucosal lymphocyte adhesion to hepatic endothelium (MAdCAM-1 in chronic inflammatory liver disease).
Grant AJ; Lalor PF; Hübscher SG; Briskin M; Adams DH
Hepatology; 2001 May; 33(5):1065-72. PubMed ID: 11343233
[TBL] [Abstract][Full Text] [Related]
14. The intestinal microbiota in inflammatory bowel diseases: time to connect with the host.
Sokol H; Seksik P
Curr Opin Gastroenterol; 2010 Jul; 26(4):327-31. PubMed ID: 20445446
[TBL] [Abstract][Full Text] [Related]
15. Subclinical gut inflammation in ankylosing spondylitis.
Ciccia F; Rizzo A; Triolo G
Curr Opin Rheumatol; 2016 Jan; 28(1):89-96. PubMed ID: 26599385
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of apoptosis (IAPs) regulate intestinal immunity and inflammatory bowel disease (IBD) inflammation.
Pedersen J; LaCasse EC; Seidelin JB; Coskun M; Nielsen OH
Trends Mol Med; 2014 Nov; 20(11):652-65. PubMed ID: 25282548
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune liver diseases and inflammatory bowel diseases in children: current issues and future perspectives.
Cardile S; Alterio T; Candusso M; Pietrobattista A; Liccardo D; Basso MS; Papadatou B; Bracci F; Knafelz D; Torre G
Scand J Gastroenterol; 2017; 52(6-7):662-667. PubMed ID: 28281846
[TBL] [Abstract][Full Text] [Related]
18. Protein tyrosine phosphatase non-receptor type 2 and inflammatory bowel disease.
Spalinger MR; McCole DF; Rogler G; Scharl M
World J Gastroenterol; 2016 Jan; 22(3):1034-44. PubMed ID: 26811645
[TBL] [Abstract][Full Text] [Related]
19. Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease.
Wang ZK; Yang YS; Chen Y; Yuan J; Sun G; Peng LH
World J Gastroenterol; 2014 Oct; 20(40):14805-20. PubMed ID: 25356041
[TBL] [Abstract][Full Text] [Related]
20. Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis.
Saarinen S; Olerup O; Broomé U
Am J Gastroenterol; 2000 Nov; 95(11):3195-9. PubMed ID: 11095341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
